RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
VAFFX
Price
$35.27
Change
+$0.43 (+1.23%)
Updated
Sep 4 closing price
Net Assets
17.86B
Interact to see
Advertisement

RGEBX vs VAFFX

Header iconRGEBX vs VAFFX Comparison
Open Charts RGEBX vs VAFFXBanner chart's image
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
Invesco American Franchise R6
Price$35.27
Change+$0.43 (+1.23%)
VolumeN/A
Net Assets17.86B
RGEBX vs VAFFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RGEBX vs. VAFFX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a Buy and VAFFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. VAFFX (17.9B). RGEBX (0.00) and VAFFX (0.00) have matching dividends . RGEBX was incepted earlier than VAFFX: RGEBX (11 years) vs VAFFX (13 years). RGEBX (1.09) is less costly to investors than VAFFX (0.63). VAFFX is a more actively managed with annual turnover of: 51.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than VAFFX: RGEBX (250) vs VAFFX (1000000). VAFFX annual gain was more profitable for investors over the last year : 22.18 vs. RGEBX (17.59). RGEBX return over 5 years is better than : 38.71 vs. VAFFX (21.22).
RGEBXVAFFXRGEBX / VAFFX
Total Expense Ratio1.090.63173%
Annual Report Gross Expense Ratio1.090.63173%
Fund Existence11 years13 years-
Gain YTD15.39810.502147%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets332B17.9B1,855%
Annual Yield % from dividends0.000.00-
Returns for 1 year17.5922.1879%
Returns for 3 years57.6178.8473%
Returns for 5 years38.7121.22182%
Returns for 10 years91.44109.2084%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
DOCS69.340.82
+1.20%
Doximity
SNDA25.80-0.03
-0.12%
Sonida Senior Living
CETX0.89N/A
-0.12%
Cemtrex In